Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/8/2018
SIETES contiene 92469 citas

 
 
 1 a 20 de 113 siguiente >>
Presentar resultados
Seleccionar todas
2. Cita con resumen
Sørup S, Benn ChS, Poulsen A, Krause TG, Aaby P, Ravn H. Live vaccine against measles, mumps, and rubella and the risk of sospital admissions for nontargeted infections. JAMA 2014;311:826-35. [Ref.ID 97158]
3. Cita con resumen
Jackson LA, Peterson D, Nelson JC, Marcy SM, Naleway AL, Nordin JD, Donahue JG, Hambidge SJ, Balsbaugh C, Baxter R, Marsh T, Madziwa L, Weintraub E. Vaccination site and risk of local reactions in children 1 through 6 years of age. Pediatrics 2013;131:283-9. [Ref.ID 94627]
4.Tiene citas relacionadas
Shapiro ED. Prevention of pneumococcal infection with vaccines: an evolving story. JAMA 2012;307:847-9. [Ref.ID 92393]
5.Tiene citas relacionadas Cita con resumen
Sun Y, Christensen J, Hviid A, Li J, Vedsted P, Olsen J, Vestergaard M. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type b. JAMA 2012;307:823-32. [Ref.ID 92392]
6. Cita con resumen
Roehr B. Vaccines rarely cause adverse events, Institute of Medicine finds. BMJ 2011;343:d5538. [Ref.ID 91897]
7.Tiene citas relacionadas
Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barré syndrome. Drug Saf 2009;32:309-23. [Ref.ID 85764]
9.Tiene citas relacionadas
Bishai DM. Global initiatives in universal childhood immunisation. Lancet 2008;372:2004-5. [Ref.ID 84760]
10. Cita con resumen
Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007;357:1903-15. [Ref.ID 81453]
11. Cita con resumen
Lanata CF. Human resources in developing countries. Lancet 2007;369:1238-9. [Ref.ID 79779]
12. Cita con resumen
Campbell OMR, Graham WJ, on behalf of The Lancet Maternal Survival Series steering group. Strategies for reducing maternal mortality: getting on with what works. Lancet 2006;368:1284-99. [Ref.ID 78143]
13. Cita con resumen
Bilous J, Eggers R, Gasse F, Jarrett S, Lydon P, Magan A, Okwo-Bele JM, Salama P, Vandelaer J, Villeneuve P, Wolfson L. A new global immunisation vision and strategy. Lancet 2006;367:1464-6. [Ref.ID 76860]
14. Cita con resumen
Anónimo. 2005 new drugs tally shows pharma could try harder. Scrip 2006;3136:21. [Ref.ID 76358]
15.
Anónimo. Whithdrawal of Infanrix HepB. WHO Drug Information 2005;19:303. [Ref.ID 76297]
17. Cita con resumen
Bryce J, Black RE, Walker N, Bhutta ZA, Lawn JE, Steketee RW. Can the world afford to save the lives of 6 million children each year?. Lancet 2005;365:2193-200. [Ref.ID 74222]
18. Cita con resumen
de Barros Miranda-Filho D, de Alencar Ximenes RA, Barone AC, Vaz VL, Vieira AG, Alburquerque VMG. Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route. BMJ 2004;328:615-7. [Ref.ID 73197]
19. Cita con resumen
Freedman LP, Waldman RJ, de Pinho H, Wirth ME, Chowdhury AMR, Rosenfield A. Transforming health systems to improve the lives of women and children. Lancet 2005;365:997-1000. [Ref.ID 73135]
20. Cita con resumen
Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N, de Bernis L, for the Lancet Neonatal Survival Steering Team. Evidence-based, cost-effective interventions: how many newborn babies can we save?. Lancet 2005;365:977-88. [Ref.ID 73134]
Seleccionar todas
 
 1 a 20 de 113 siguiente >>